Atreca could gain 100% with positive data for cancer drug: Jefferies
Atreca (BCEL) shares gained ~7% intraday after Jefferies reaffirmed its positive view on the company
Atreca (BCEL) shares gained ~7% intraday after Jefferies reaffirmed its positive view on the company
Shares fall 17% a day after sending founder Richard Branson into space on news the company could sell up…
I once performed a Google search to determine the core premises of Modern Portfolio Theory. The answer that came…
Musk testified Monday to defend Tesla’s acquisition of SolarCity against suit claiming he’s to blame for deal rife with…
ING to transfer Retail Banking operations, staff and customers in Austria to bank99 ING announced today it has reached…
Bytedance reportedly paused its IPO after a chat with regulators, saving it and CEO Zhang Yiming from being publicly…
BLOOMFIELD, Conn.–(BUSINESS WIRE)–Kaman Corp. (NYSE:KAMN) announced today that it will report its second quarter 2021 results…
Byrna Technologies Inc. (NASDAQ: BYRN) (CSE: BYRN) (“Byrna” or “the Company”) today announced that it has launched an underwritten…
In a flexicap fund, the fund manager plans portfolio allocation across sectors
HOUSTON, July 12, 2021 (GLOBE NEWSWIRE) — Amplify Energy Corp. (NYSE: AMPY) (“Amplify” or the “Company”) announced today that…